2019 Levy Lecture Series welcomes Hartmut Derendorf, PhD

L-R: Dean James O’Donnell, PhD, Harmut Deredorf, PhD, and Marilyn Morris, PhD, SUNY Distinguished Professor of Pharmaceutical Sciences and Chair, Department of Pharmaceutical Sciences.

L-R: Dean James O’Donnell, PhD, Harmut Deredorf, PhD, and Marilyn Morris, PhD, SUNY Distinguished Professor of Pharmaceutical Sciences and Chair, Department of Pharmaceutical Sciences

By Kara Sweet

Published November 20, 2019

Hartmut Derendorf, PhD, Distinguished Professor Emeritus in the Department of Pharmaceutics at the University of Florida College of Pharmacy, was the guest speaker for the 2019 Gerhard Levy Lectureship in Pharmaceutical Sciences.

Print

His lecture, “Why MIC is Poison for the Mind,” was an exploration of the pharmacokinetics and pharmacodynamics of minimum inhibitory concentration (MIC).

The Gerhard Levy Lectureship was established in 2000 in recognition of the significant contributions Levy made in his fields of study and to honor an esteemed colleague who deftly balanced his love of teaching with robust research. Derendorf called Levy "one of the most influential scientists of my career."

The lecture was held Monday, Nov. 18, in the Pharmacy Building on the University at Buffalo South Campus, and an evening dinner was also held in Derendorf’s honor.

“Professor Derendorf has made significant contributions in clinical pharmacology and translational research of corticosteroids, antibiotics and analgesics, and in mentoring PharmD, graduate students and post-doctoral fellows,” remarked Marilyn Morris, SUNY Distinguished Professor and chair, Department of Pharmaceutical Sciences.

Derendorf's research interests include the pharmacokinetics and pharmacodynamics of corticosteroids, analgesics and antibiotics, as well as drug interactions. He has published over 490 scientific publications (h-index Google Scholar 68, Scopus 58) and given over 900 presentations at national and international meetings. He is editor or associate editor of the Journal of Clinical Pharmacology, International Journal of Clinical Pharmacology and Therapeutics, International Journal of Antimicrobial Agents and Die Pharmazie, and serves on the editorial board of several other journals.

He is a Fellow of the American Association of Pharmaceutical Scientists (AAPS) and the American College of Clinical Pharmacology (ACCP). In 2010, he was awarded the American Association of Colleges of Pharmacy Volwiler Research Achievement Award as well as the ACCP Distinguished Investigator Award, the highest research awards of both organizations.

For over 130 years, the University at Buffalo School of Pharmacy and Pharmaceutical Sciences has continually been a leader in the education of pharmacists and pharmaceutical scientists, renowned for innovation in clinical practice and research. The school is accredited by the American Council of Pharmaceutical Education (ACPE) and is the No. 1 ranked school of pharmacy in New York State and No. 22 in the United States by U.S. News & World Report.